|Impact of Rural and Urban Hospital Closures on Inpatient Mortality|
with Kritee Gujral: w26182
|The New Prescription Drug Paradox: Pipeline Pressure and Rising Prices|
with Alice M. Ellyson: w24387
|Service-level Selection: Strategic Risk Selection in Medicare Advantage in Response to Risk Adjustment|
with Sungchul Park, Norma Coe, Fahad Khalil: w24038
|Comparing 2SLS vs 2SRI for Binary Outcomes and Binary Exposures|
with Norma Coe, Cole G. Chapman: w23840
|Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion|
with Caroline S. Bennette, Scott D. Ramsey, Zachary Helms, Peter B. Bach: w23842
Published: Caroline Savage Bennette & Anirban Basu & Scott D. Ramsey & Zachary Helms & Peter B. Bach, 2019. "Health Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion," American Journal of Health Economics, vol 5(3), pages 360-375.
|Price Elasticities of Pharmaceuticals in a Value-Based-Formulary Setting|
with Kai Yeung, Ryan N. Hansen, Sean D. Sullivan: w22308
Published: Kai Yeung & Anirban Basu & Ryan N. Hansen & Sean D. Sullivan, 2018. "Price elasticities of pharmaceuticals in a value based-formulary setting," Health Economics, vol 27(11), pages 1788-1804.
|The Roles of Cognitive and Non-Cognitive Skills in Moderating the Effects of Mixed-Ability Schools on Long-Term Health|
with Andrew M. Jones, Pedro Rosa Dias: w20811
|Political Polarization, Anticipated Health Insurance Uptake and Individual Mandate: A view from the Washington State|
with Norma B. Coe, David E. Grembowski, Larry Kessler: w20655
|Welfare Implications of Learning Through Solicitation versus Diversification in Health Care|
Published: Anirban Basu, 2015. "Welfare implications of learning through solicitation versus diversification in health care," Journal of Health Economics, vol 42, pages 165-173. citation courtesy of
|Estimating Person-Centered Treatment (PeT) Effects Using Instrumental Variables|
Published: Basu A. Person-Centered Treatment (PeT) effects using instrumental variables: An application to evaluating prostate cancer treatments.. 2012 National Bureau of Economic Research Working Paper No w18056. Journal of Applied Econometrics 2014; 29:671-691.
|Economics of Individualization in Comparative Effectiveness Research and a Basis for a Patient-Centered Health Care|
Published: Basu, Anirban, 2011. "Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care," Journal of Health Economics, Elsevier, vol. 30(3), pages 549-559, May. citation courtesy of
|The Impact of Comparative Effectiveness Research on Health and Health Care Spending|
with Tomas J. Philipson: w15633
Published: Basu, Anirban & Jena, Anupam B. & Philipson, Tomas J., 2011. "The impact of comparative effectiveness research on health and health care spending," Journal of Health Economics, Elsevier, vol. 30(4), pages 695-706, July. citation courtesy of
|The impact of Medicare Part D on Medicare-Medicaid Dual-eligible Beneficiaries' Prescription Utilization and Expenditures|
with Wesley Yin, G. Caleb Alexander: w14413
Published: A Basu & W Yin & GC Alexander, 2009. "PHP26 THE IMPACT OF MEDICARE PART D ON MEDICARE-MEDICAID DUAL-ELIGIBLE BENEFICIARIES' PRESCRIPTION UTILIZATION AND EXPENDITURES," Value in Health, vol 12(3).
|Use of Propensity Scores in Non-Linear Response Models: The Case for Health Care Expenditures|
with Daniel Polsky, Willard G. Manning: w14086
|Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data|
with Willard G. Manning, John Mullahy: t0293
Published: Manning, Willard G., Anirban Basu and John Mullahy. "Generalized Modeling Approaches To Risk Adjustment Of Skewed Outcomes Data," Journal of Health Economics, 2005, v24(3,May), 465-488.